[1]
M. Rosenstein and W. Thomson, “Impact of Internal Mechanisms on Corporate Governance: Case of Glaxosmithkline Pharmaceuticals Limited, United Kingdom”, journal-of-public-policy-governa, vol. 5, no. 3, pp. 1–10, Sep. 2021.